35947848|t|Angiotensin converting enzyme inhibitor captopril prevents neuronal overexpression of amyloid-beta and alpha-synuclein in Drosophila melanogaster genetic models of neurodegenerative diseases.
35947848|a|BACKGROUND: Parkinson disease (PD) and Alzheimer's disease (AD) are progressive neurodegenerative disorders characterized by loss of selective neurons in discreet part of the brain. The peptide angiotensin II (Ang II) plays significant role in hippocampal and striatal neurons degeneration through the generation of reactive oxygen species. Blockade of the angiotensin converting enzyme or ATI receptors provides protection in animal models of neurodegenerative diseases. In the present study, the neuroprotective effect of captopril was investigated in Drosophila melanogaster model using the UAS-GAL4 system to express the synuclein and Abeta42 peptide in the flies' neurons. METHODS: The disease causing human Abeta42 peptide or alpha-syn was expressed pan-neuronally (elav-GAL4) or dopamine neuron (DDC-GAL4) using the UAS-GAL4 system. Flies were either grown in food media with or without captopril (1, 5, or 10microM). This was followed by fecundity, larva motility, negative geotaxis assay (climbing) and lifespan as a measure of neurodegeneration. RESULTS: Elav-Gal4<Abeta or DDC-GAL4<alpha-syn flies displayed significant decrease in larva motility when compared with normal control (w1118) which was reversed by the supplementation of the media with captopril (5 or 10 mM) indicative of neuroprotection. Interestingly, supplementation of flies' media with captopril improved climbing activity in Elav-Gal4<Abeta or DDC-GAL4<alpha-syn flies when compared with vehicle treated only. Moreover, flies grown on captopril caused no significant change in lifespan.  Conclusion: Findings from this study confirmed the neuroprotective action of captopril in genetic or familial forms of neurodegeneration.
35947848	0	29	Angiotensin converting enzyme	Gene	34805
35947848	40	49	captopril	Chemical	MESH:D002216
35947848	122	145	Drosophila melanogaster	Species	7227
35947848	164	190	neurodegenerative diseases	Disease	MESH:D019636
35947848	204	221	Parkinson disease	Disease	MESH:D010300
35947848	223	225	PD	Disease	MESH:D010300
35947848	231	250	Alzheimer's disease	Disease	MESH:D000544
35947848	252	254	AD	Disease	MESH:D000544
35947848	272	299	neurodegenerative disorders	Disease	MESH:D019636
35947848	386	400	angiotensin II	Gene	183
35947848	402	408	Ang II	Gene	183
35947848	461	481	neurons degeneration	Disease	MESH:D009410
35947848	508	531	reactive oxygen species	Chemical	MESH:D017382
35947848	549	578	angiotensin converting enzyme	Gene	34805
35947848	636	662	neurodegenerative diseases	Disease	MESH:D019636
35947848	716	725	captopril	Chemical	MESH:D002216
35947848	746	769	Drosophila melanogaster	Species	7227
35947848	831	838	Abeta42	Gene	351
35947848	899	904	human	Species	9606
35947848	905	912	Abeta42	Gene	351
35947848	964	968	elav	Gene	31000
35947848	978	986	dopamine	Chemical	MESH:D004298
35947848	995	998	DDC	Gene	35190
35947848	1086	1095	captopril	Chemical	MESH:D002216
35947848	1229	1246	neurodegeneration	Disease	MESH:D019636
35947848	1257	1261	Elav	Gene	31000
35947848	1267	1272	Abeta	Gene	31002
35947848	1276	1279	DDC	Gene	35190
35947848	1452	1461	captopril	Chemical	MESH:D002216
35947848	1558	1567	captopril	Chemical	MESH:D002216
35947848	1598	1602	Elav	Gene	31000
35947848	1608	1613	Abeta	Gene	351
35947848	1617	1620	DDC	Gene	35190
35947848	1708	1717	captopril	Chemical	MESH:D002216
35947848	1838	1847	captopril	Chemical	MESH:D002216
35947848	1880	1897	neurodegeneration	Disease	MESH:D019636
35947848	Negative_Correlation	MESH:D002216	MESH:D000544
35947848	Negative_Correlation	MESH:D002216	31002
35947848	Negative_Correlation	MESH:D002216	35190
35947848	Negative_Correlation	MESH:D002216	31000
35947848	Negative_Correlation	MESH:D002216	MESH:D019636
35947848	Positive_Correlation	MESH:D017382	183
35947848	Negative_Correlation	MESH:D002216	351
35947848	Association	MESH:D009410	183
35947848	Negative_Correlation	MESH:D002216	34805

